HARBOUR INVESTMENT MANAGEMENT LLC
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1275880
EDMONDS, WA
Position in PLX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$23,533
+$1,616 QoQ
Shares Held
10,100
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#67
of 101 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENT MANAGEMENT LLC holds $23,533 across 1 Biotechnology name. PLX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PLX |
Protalix BioTherapeutics, Inc.
This page
|
10,100 | $23,533 |
All Filings in PLX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,533 | 10,100 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $21,917 | 10,100 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $18,180 | 10,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,422 | 10,100 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $14,948 | 10,100 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $25,856 | 10,100 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $18,988 | 10,100 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $10,302 | 10,100 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $11,817 | 10,100 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $12,726 | 10,100 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $17,978 | 10,100 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $16,766 | 10,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,200 | 10,100 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||